NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 73 filers reported holding NEOS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 693,582 | $4,057,000 | 2.30% |
DAFNA Capital Management LLC | 38,873 | $227,000 | 0.20% |
FALCON POINT CAPITAL, LLC | 85,588 | $501,000 | 0.07% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 229,166 | $1,341,000 | 0.06% |
Cormorant Asset Management, LP | 50,613 | $296,000 | 0.04% |
PRELUDE CAPITAL MANAGEMENT, LLC | 14,587 | $85,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,000 | $468,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 296,175 | $1,733,000 | 0.00% |
FRANKLIN RESOURCES INC | 1,315,500 | $7,696,000 | 0.00% |
COLUMBUS CIRCLE INVESTORS | 42,304 | $247,000 | 0.00% |